PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 4,400 shares, an increase of 1,000.0% from the December 31st total of 400 shares. Based on an average daily volume of 233,200 shares, the days-to-cover ratio is currently 0.0 days.

PURE Bioscience Trading Up 5.3 %

OTCMKTS:PURE traded up $0.00 during mid-day trading on Wednesday, reaching $0.07. The company’s stock had a trading volume of 100,915 shares, compared to its average volume of 78,395. The firm’s fifty day moving average price is $0.07 and its two-hundred day moving average price is $0.08. The stock has a market cap of $8.21 million, a P/E ratio of -1.84 and a beta of 0.07. PURE Bioscience has a 12-month low of $0.06 and a 12-month high of $0.16.

PURE Bioscience (OTCMKTS:PURE) last posted its earnings results on Monday, December 16th. The company reported ($0.01) EPS for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.